Joanna Pierro, DO

Eleny Romanos-Sirakis, MD, MS, FAAP is a board-certified specialist in pediatric hematology/oncology and is the Director of Pediatric Hematology and Oncology at Staten Island University Hospital (SIUH). She has advanced and expanded the care for patients undergoing evaluation and treatment for cancer and blood disorders at SIUH. She provides comprehensive care to patients from infancy to 21 years of age. Dr. Romanos provides clinical evaluations and treatments for a wide variety of hematology and oncology concerns, including anemia, low or high white blood cell counts, low or high platelet counts, bleeding disorders, clotting disorders, sickle cell disease, thalassemia, hemoglobinopathies, enlarged lymph nodes, bone tumors, histiocytosis, leukemia, lymphoma, and solid tumors. Dr. Romanos came to SIUH from NYU Langone Medical Center in Manhattan, where she specialized in pediatric cancers and blood disorders. She brings this expertise to Staten Island and provides this high-quality specialty care locally, removing the need for patients to leave Staten Island for evaluations and treatments. She understands that all children have unique needs and is dedicated to providing personalized care to meet the individualized needs of her patients and their entire families. She has specialized and extensive training in the care of children with special needs; Dr Romanos and her entire team work to ensure that the needs of each family are met in this personalized approach to treating each child. Families' specific needs or requests should be communicated to the office staff when scheduling appointments; every effort will be made to accommodate each patient and family. Providing optimal care and assessments, while maximizing patient and family quality of life, is of highest priority for Dr. Romanos. She has additional training in pediatric pain management and was actively involved in developing the SIUH Pediatric Comfort Campaign to minimize pain for children undergoing procedures and improve overall pain management for pediatric patients. She is committed to education and research at SIUH; she is actively involved in further advancing research at SIUH as the chair of the pediatric research and scholarship committee. She is also an active committee member of the American Society of Pediatric Hematology/Oncology and the American Academy of Pediatrics. Dr. Romanos is a native New Yorker and is dedicated to providing personalized and high-quality care to all of her patients.

Terenig Terjanian, MD, is a hematologist and medical oncologist at Northwell Health, and an assistant professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Growing up in Lebanon, Dr. Terjanian’s early love for biology and chemistry set him on the path toward medicine. After attending St. Joseph’s University, he did a residency in pathology at American University of Beirut Medical Center, and one in internal medicine at Staten Island University Hospital. He then did fellowships in hematology and oncology at NYU Grossman School of Medicine and University of Texas MD Anderson Cancer Center. Although he initially specialized in pathology, Dr. Terjanian chose cancer care as a main focus after coming to the United States in 1981. "The number one thing I want patients to know is that I'll listen to them," he says. "I try to go over every aspect of their disease slowly, explain why we order the tests we do, and have them be completely aware of all the steps," he says, adding that he often gives patients his cell number, because he knows concerns can come up anytime. "I think of what I would want as a patient, and it would be a doctor who really cares." Dr. Terjanian is deeply interested in clinical research. He has been the principal investigator on several protocols, including those of the National Surgical Adjuvant Breast and Bowel Project at Staten Island University Hospital, and has published multiple peer-reviewed papers and abstracts and presented at international meetings. He also runs the research committee for medical residents interested in hematology-oncology, and for fellows in that specialty. He's a member of the system-wide Institutional Review Board, a group that ensures clinical trials are done ethically and safely. In addition to participation in weekly tumor board meetings, and frequently providing lectures for interns and residents, Dr. Terjanian still enjoys the chemistry and biology that drew him to medicine from the start, especially since the science in oncology changes so rapidly – which leads to improved patient outcomes. "Every day, there is something new happening in cancer diagnosis and treatment, and it's exciting to see that progress," he says. "Patients are living longer, they're experiencing better quality of life with targeted therapy or immunotherapy. It’s immensely satisfying to see how far we've come."